DRKS00006842招募中未知
Clinical study over a period of at least 6 months to an individualized strength and endurance training in COPD patients in Marburger - IT vs. CG by ambulatory COPD rehabilitation
Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Germany, Member of the German Center for Lung Research (DZL)0 个研究点目标入组 48 人开始时间: 2014年10月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients diagnosed with COPD, patients of stage I - IV or AD (according to GOLD classification)
排除标准
- •Regard to acute pathological cardiac events (e.g. heart attack), comorbidities such as heart failure (NYHA III and IV), congestive heart failure, high blood pressure (> 220/120 mmHg), severe mental illness, cognitive impairments, limitations of the musculoskeletal system, which make a training impossible, neurological diseases that affect the training and implementation, acute exacerbations, acute inflammation / infection
研究者
相似试验
已完成
不适用
Effects of Hintonia latiflora in type 2 diabeticsMild and moderate diabetes mellitus of type II (age-related)Nutritional, Metabolic, EndocrineISRCTN83308122Gehrlicher Pharmazeutische Extrakte GmbH (Germany)40
已完成
不适用
The effect of inhaled corticosteroids (ICS) on airway inflammation in chronic obstructive pulmonary disease (COPD)chronic obstructive pulmonary disease (COPD)Respiratory - Chronic obstructive pulmonary diseaseACTRN12612001111864GlaxoSmithKline's (GSK)34
已完成
2 期
Randomized trial of clinical effect of 6 months or 3months Gn-RH agonist (Goserelin acetate 1.8mg) to endometriosis comlicated uterine myomaJPRN-UMIN000026073Department of Obstetrics and Gynecology Nara Medical University80
进行中（未招募）
1 期
Efficacy study to evaluate fluticasone furoate /vilanterol Inhalation Powder delivered once daily via the Dry Powder Inhaler Ellipta™ compared with usual ICS/LABA maintenance therapy delivered by Dry Powder Inhaler in subjects with Persistent AsthmaSubject with persistent asthmaMedDRA version: 19.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2014-000551-81-DEGlaxoSmithKline Research & Development Limited422
已完成
3 期
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye SyndromeSjogren's SyndromeLupus Erythematosus, SystemicArthritis, RheumatoidScleroderma, SystemicKeratoconjunctivitis SiccaNCT00025818Allergan290